FDA finds low levels of possible carcinogen in Zantac
FDA finds low levels of possible carcinogen in Zantac

FDA finds low levels of possible carcinogen in Zantac

The FDA announced Friday that it found low levels of a possible carcinogen in Zantac and other heartburn medications.

Latest LiveNOW Stories

From the Archives

Consumer & Money

Science & Tech

Police Chases

Weather Across the Country